| Literature DB >> 25396055 |
Vibeke Brogaard Hansen1, Helle Terkildsen Maindal2.
Abstract
OBJECTIVES: In Denmark, the local and regional health authorities share responsibility for cardiac rehabilitation (CR). The objective was to assess effectiveness of CR across sectors coordinated by a nurse case manager (NCM).Entities:
Keywords: Cardiac rehabilitation; depression; health status; nurse case manager; prevention; public health policy; self-care management; shared care
Year: 2014 PMID: 25396055 PMCID: PMC4229057 DOI: 10.1177/2048004014555922
Source DB: PubMed Journal: JRSM Cardiovasc Dis ISSN: 2048-0040
Figure 1.Flow chart of the cardiac multidisciplinary rehabilitation programme for cohort (GoHeart).
Key components of the nurse case management at the Department of Cardiology, Lillebaelt Hospital, Vejle, Denmark.
| Administration | Direct patient support | Enhanced support for vulnerable patients |
|---|---|---|
| Management of the patient distribution to cardiac rehabilitationa Booking and alter the course as individually required with focus on minimizing opt-outs Focus on vacant training and educational course ensuring max capacity and short waiting time Facilitate and inform the patientsa Arrange transport and interpreter as neededa Follow-up when patient fails to appear Electronic and verbal communication between collaborative professionalsa Arrange meetings for the rehabilitation team both interdisciplinary and cross-sectorial Contact by the Department to the Municipal Authorities and the General Practitioners | Inform the patients about the cardiac rehabilitation treatment measures and opportunitiesa Individual adjustment Based on stratification, clarify needs, resources and motivation Provide guidance to patients by telephone through a ‘hotline’ and writing by mailbox Ensure individual nurse contact ‘Life line’ | Optimise the course individually with the aim of receiving an entire or, as minimum, part of the recommended cardiac rehabilitation Opportunity of individual counseling Telephone message to the general practitioner when discharged from hospital |
aUsual cardiac rehabilitation.
Figure 2.Flow chart for the GoHeart-study.
Clinical characteristics at baseline of the participants in the study cohort (GoHeart) compared to non-responders and non-participants.
| Participants | Non-responders | Non-participants | ||||||
|---|---|---|---|---|---|---|---|---|
| All | All | All | ||||||
| Characteristics | Female | Male | ||||||
| Female | 44 (24.0) | 19 (32.8) | 0.188 | 15 (29.4) | 0.435 | |||
| Male | 139 (76.0) | 39 (67.2) | 36 (70.6) | |||||
| Age (years), mean (SD) | 63.8 (9.0) | 66.5 (9.7) | 62.9 (8.6) | 0.020 | 61.6 (13.0) | 0.161 | 68.0 (11.6) | 0.006 |
| MI | ||||||||
| NSTEMI | 38 (20.8) | 12 (27.3) | 26 (18.7) | 0.286 | 15 (25.9) | 0.467 | 10 (19.6) | 1.000 |
| STEMI | 32 (17.5) | 5 (11.4) | 27 (19.4) | 0.262 | 5 (8.6) | 0.142 | 1 (2.0) | 0.003 |
| Treatment | ||||||||
| PCI | 121 (66.1) | 29 (65.9) | 92 (66.2) | 1,000 | 42 (72.4) | 0,423 | 36 (70.6) | 0,615 |
| CABG | 32 (17.5) | 2 (4.6) | 30 (21.6) | 0.011 | 7 (12.1) | 0.415 | 6 (11.8) | 0.395 |
| Aortic substitution ± revascularisation | 3 (1.6) | 2 (4.6) | 1 (0.7) | 0.144 | 1 (17) | 1.000 | 3 (5.9) | 0.119 |
| Mitral substitution ± revascularisation | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (2.0) | 0.218 | ||
| Conservative strategy | 33 (18.0) | 12 (27.3) | 21 (15.1) | 0.075 | 9 (15.5) | 0.843 | 7 (13.7) | 0.535 |
| Known IHD | 38 (20.8) | 10 (22.7) | 28 (20.1) | 0.677 | 15 (25.9) | 0.467 | 19 (37.3) | 0.026 |
| Family history of IHD | 92 (50.3) | 23 (52.3) | 69 (49.6) | 0.863 | 27 (46.6) | 0.653 | 23 (45.1) | 0.531 |
| Smoking history | ||||||||
| Current smokers | 23 (12.6) | 8 (18.2) | 15 (10.8) | 33 (58.9) | <0.0001 | 18 (36.0) | 0.001 | |
| Previous smoker | 105 (57.4) | 21 (47.7) | 84 (60.4) | 0.250 | 14 (25.0) | 18 (36.0) | ||
| Never smokers | 55 (30.1) | 15 (34.1) | 40 (28.8) | 9 (16.1) | 14 (28.0) | |||
| Diabetes | ||||||||
| Only diet treatment | 7 (3.8) | 0 (0.0) | 7 (5.0) | 0.199 | 4 (6.9) | 0.303 | 2 (3.9) | 1.000 |
| Medically treated with tablets | 18 (9.8) | 3 (6.8) | 15 (10.8) | 0.569 | 8 (13.8) | 0.466 | 3 (5.9) | 0.580 |
| Medically treated with insulin | 10 (5.5) | 4 (9.1) | 6 (4.3) | 0.256 | 9 (15.5) | 0.022 | 5 (9.8) | 0.329 |
| Medically treated hypertension | 129 (70.5) | 30 (68.2) | 99 (71.2) | 0.708 | 36 (62.1) | 0.257 | 40 (78.4) | 0.294 |
| Hypercholesterolemia | 167 (91.3) | 38 (86.4) | 129 (92.8) | 0.221 | ||||
| Diet treated | 2 (1.1) | 0 (0.0) | 2 (1.4) | 1,000 | 0 (0.0) | 1.000 | 3 (5.9) | 0.071 |
| Medically treated | 148 (80.9) | 34 (77.3) | 114 (82.0) | 0.512 | 58 (100) | <0.0001 | 48 (94.1) | 0.030 |
| Exercise habits (s 30 min per day) | ||||||||
| 0 days per week | 94 (51.4) | 22 (50.0) | 72 (51.8) | 0.783 | 26 (44.8) | <0.0001 | 22 (43.1) | 0.001 |
| 1–2 days per week | 22 (12.0) | 5 (11.4) | 17 (12.2) | 22 (38.0) | 19 (37.3) | |||
| 3–4 days per week | 25 (13.7) | 8 (18.2) | 17 (12.2) | 5 (8.6) | 4 (7.8) | |||
| >4 days per week | 42 (23.0) | 9 (20.5) | 33 (23.7) | 5 (8.6) | 6 (11.8) | |||
| Alcohol consumption (>7/14 units per week) | 24 (13.1) | 1 (2.3) | 23 (16.6) | 0.011 | 5 (8.6) | 0.488 | 9 (17.7) | 0.494 |
| Obesity (BMI, kg/m2) | ||||||||
| Obese (s 30) | 44 (24.0) | 10 (22.7) | 35 (25.2) | <0.0001 | 4 (7.1) | 0.004 | 18 (35.3) | 0.110 |
| Overweight (25–30) | 94 (51.4) | 14 (31.8) | 80 (57.6) | 28 (50.0) | 18 (35.3) | |||
| Normal (<25) | 45 (24.6) | 20 (45.5) | 24 (17.3) | 24 (42.9) | 15 (29.4) | |||
| Lung disease | 16 (8.7) | 5 (11.4) | 11 (7.9) | 0.541 | 12 (20.7) | 0.019 | 10 (19.6) | 0.042 |
| Ischaemic stroke | 11 (6.0) | 3 (6.8) | 8 (5.8) | 0.727 | 5 (8.6) | 0.545 | 7 (13.7) | 0.078 |
| Peripheral vascular disease | 12 (6.6) | 1 (2.3) | 11 (7.9) | 0.299 | 6 (10.3) | 0.390 | 4 (7.8) | 0.756 |
| Renal failure | 1 (0.6) | 0 (0.0) | 1 (0.7) | 1.000 | 0 (0.0) | 1.000 | 4 (7.8) | 0.009 |
| Medical treated mental depression | 10 (5.5) | 3 (6.8) | 7 (5.0) | 0.705 | 7 (12.1) | 0.136 | 6 (11.8) | 0.124 |
| Musculoskeletal disease | 17 (9.3) | 5 (11.4) | 12 (8.6) | 0.561 | 13 (22.4) | 0.012 | 3 (5.9) | 0.578 |
| High | 139 (76.0) | 38 (86.4) | 101 (72.7) | 0.071 | <0.0001 | <0.0001 | ||
| Low | 44 (24.0) | 6 (13.6) | 38 (27.3) | 30 (51.7) | 29 (56.9) | |||
NSTEMI: non-ST segment myocardial infarction; STEMI: ST segment myocardial infarction; PCI: percutaneous transluminal coronary intervention; CABG: coronary artery bypass graft; IHD: ischaemic heart disease; stratification; according to the Chronic Care Model; BMI: body mass index.
Values are numbers (%) unless stated mean (SD).
Outcome after cardiac rehabilitation for cohort at admission compared to three months at discharge and at one-year follow-up.a
| Study variable | Admission to CR | 3 months at discharge | 12 months follow-up | Differences | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular risk factors | 0–3 mo | 3–12 mo | |||||||||
| BMI (kg/m2), mean (SD) | 183 | 27.5 | 3.8 | 178 | 27.5 | 3.8 | 183 | 27.3 | 4.0 | 0.890 | 0.026 |
| Blood pressure (mmHg), mean (SD) | |||||||||||
| Systolic | 183 | 135.5 | 19.5 | 182 | 136.9 | 18.6 | 182 | 138.7 | 19.8 | 0.345 | 0.299 |
| Diastolic | 183 | 79.8 | 11.4 | 182 | 81.2 | 9.8 | 182 | 83.9 | 9.7 | 0.073 | 0.0005 |
| Blood test (non-fasting), mean (SD) | |||||||||||
| Total-cholesterol (mmol/l) | 183 | 4.2 | 1.0 | 183 | 3.9 | 0.8 | 183 | 3.9 | 0.7 | <0.0001 | 0.316 |
| LDL (mmol/l) | 181 | 2.4 | 0.8 | 183 | 2.1 | 0.6 | 183 | 2.1 | 0.6 | <0.0001 | 0.459 |
| HDL (mmol/l) | 181 | 1.3 | 0.5 | 183 | 1.3 | 0.4 | 183 | 1.4 | 0.4 | 0.130 | 0.027 |
| Triglyceride (mmol/l) | 181 | 1.5 | 0.9 | 183 | 1.5 | 0.9 | 182 | 1.5 | 1.0 | 0.110 | 0.735 |
| HbA1c (%)* | 32 | 0.070 | 0.011 | 31 | 0.069 | 0.013 | 32 | 0.070 | 0.014 | 0.400 | 0.463 |
| Medication intake | |||||||||||
| Aspirin | 183 | 179 | 97.8 | 181 | 175 | 96.7 | 183 | 177.0 | 96.7 | NS | |
| Clopidogrel/Prasugrel | 183 | 134 | 73.2 | 181 | 132 | 72.9 | 181 | 89.0 | 48.6 | ||
| Statin | 183 | 174 | 95.1 | 181 | 173 | 95.6 | 183 | 173.0 | 94.5 | ||
| Non-statin | 183 | 6 | 3.3 | 181 | 6 | 3.3 | 183 | 7.0 | 3.8 | ||
| Beta-blocker | 183 | 127 | 69.4 | 181 | 120 | 66.3 | 183 | 117.0 | 63.9 | ||
| ACE-inhibitor | 183 | 63 | 34.4 | 181 | 65 | 35.9 | 183 | 80.0 | 43.7 | ||
| Lifestyle behaviours | |||||||||||
| Alcohol consumption (>7/14 units per week) | 183 | 20 | 11.0 | 181 | 24 | 13.3 | 183 | 25.0 | 13.8 | 0.102 | 0.564 |
| Current smokers | |||||||||||
| Number | 183 | 22 | 12.1 | 181 | 19 | 10.5 | 181 | 18.0 | 9.9 | 0.083 | 0.655 |
| Cigarettes a day, mean (SD) | 10 | 7.2 | 21 | 8 | 5.5 | 21 | 8.5 | 6.2 | 0.170 | 1 | |
| Combined treadmill exercise/Borg15 talk | |||||||||||
| Test, mean (SD) | |||||||||||
| METS at Borg15 | 176 | 7.5 | 1.9 | 100 | 8.3 | 1.3 | 172 | 8.3 | 2.6 | 0.007 | 0.788 |
| Alternative 6MWT (meter) | 7 | ||||||||||
| Psycosocial | |||||||||||
| Self-care management | |||||||||||
| High | 183 | 139 | 76.0 | 183 | 161 | 88.0 | 183 | 168.0 | 91.8 | 0.0002 | 0.071 |
| Low | 183 | 44 | 24.0 | 183 | 22 | 12.0 | 183 | 15.0 | 8.2 | ||
| Health status, mean (SD) | |||||||||||
| SF12 physical component score (pcs) | 137 | 44 | 9.9 | 137 | 48.8 | 9.1 | <0.0001 | ||||
| SF12 mental component score (mcs) | 137 | 50 | 10.8 | 137 | 52.3 | 8.9 | 0.005 | ||||
| SF12 physical component score (pcs) | 141 | 48.7 | 9.2 | 141 | 47 | 10.4 | 0.002 | ||||
| SF12 mental component score (mcs) | 141 | 53.0 | 8.4 | 141 | 53 | 9.7 | 0.899 | ||||
| Anxiety | |||||||||||
| HADS-A <8 | 161 | 125 | 77.6 | 161 | 134 | 83.2 | 161 | 137 | 85.1 | 0.083 | 0.5637 |
| HADS-A >8 | 161 | 36 | 22.4 | 161 | 27 | 16.8 | 161 | 24 | 14.9 | ||
| Depression | |||||||||||
| HADS-D <8 | 161 | 138 | 85.7 | 161 | 148 | 91.9 | 161 | 149 | 92.5 | 0.0075 | 0.7055 |
| HADS-D >8 | 161 | 23 | 14.3 | 161 | 13 | 8.1 | 161 | 12 | 7.4 | ||
mo: months; NS: non significant; BMI: body mass index; METS: 3,5 ml O2/kg/min; 6MWT: 6-min walk test; *HbA1c: only measured for diabetic.
aSelf-care management was determined after stratification according to the Chronic Care Model. Health status (SF-12v2) and Hospital Anxiety and Depression Scale (HADS); estimated data were calculated for participants who responded at both control times. Physical component score (pcs) and mental component score (mcs). Continuous clinical variable, self-care management, Short-Form 12 version 2 (SF-12v2) and Hospital Anxiety and Depression score (HADS). Values are numbers (%) unless stated.